Navigation Links
Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
Date:11/1/2011

Medical Officer. "We continue to believe that interferon remains the greatest impediment to care for a majority of the millions of individuals living with HCV.  PSI-7977 has demonstrated high cure rates, without viral resistance, and across HCV genotypes; we hope to confirm these benefits in these registrational studies."

About FISSON

FISSION will be conducted at more than 100 centers in the US, Europe and other territories. The trial will enroll approximately 500 treatment-naive patients with HCV genotype 2 or 3 into one of two open-label regimens:

  • PSI-7977 400 mg QD with ribavirin for 12 weeks
  • the current standard-of-care for HCV GT2/3, pegylated interferon and ribavirin for 24 weeks

The study will include patients with and without cirrhosis, and will enroll a greater proportion of patients with HCV genotype 3, who are less likely to achieve an SVR with the currently available therapy, pegylated interferon and ribavirin.  The primary endpoint of the trial will be SVR12. Enrollment is anticipated to begin by the end of 2011.

About POSITRON

POSITRON will be conducted at more than 100 centers in the US, Europe and other territories.  The trial will enroll patients with HCV genotype 2 or 3 who cannot take interferon into one of two blinded regimens:

  • PSI-7977 400 mg QD with ribavirin for 12 weeks
  • placebo PSI-7977 and placebo ribavirin

POSITRON will enroll approximately 225 patients with or without cirrhosis.  The primary endpoint of the trial will be SVR12. Enrollment is anticipated to begin in the first quarter of 2012.

About NEUTRINO

NEUTRINO will enroll approximately 280 patients who cannot take interferon. The study will be conducted at more than 100 centers in the US, Europe and other territories. The final design of the trial will be based on em
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... WASHINGTON , July 23, 2014  Nearly 8,000 ... for Cardinal Health,s annual Retail Business Conference (RBC), ... & Convention Center. This year,s event encourages pharmacists to ... in their communities and for their future. ... pharmacy owners to network with their peers and learn ...
(Date:7/23/2014)... July 23, 2014  The management team at ... will hold a conference call on July 31, ... quarter ended June 30, 2014.  The call details ... , 8:30 am EDTDial-in numbers: , Toll free: ... 317-0790Webcast (live & archive): , www.columbialabs.com , ...
(Date:7/23/2014)... , July 23, 2014 This September ... in Las Vegas for ... by educator, author, forward thinker and private practitioner Dr. ... experts together to candidly discuss clinical and practice management ... event is a unique opportunity to welcome fresh thinking ...
Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... Luminex Corporation (NASDAQ: LMNX ) today announced ... Inc., an innovator in molecular diagnostic testing technologies for ... cash. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... million and $7 million to 2011 consolidated revenue. On ...
... Providers of durable medical equipment and services (DME) required in ... controversial "competitive" bidding for homecare, which cuts quality and access ... The program is opposed by the American Association ... such as the ALS Association and the ...
Cached Medicine Technology:Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 2Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 3At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 2At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 3At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 4
(Date:7/23/2014)... The European Vitamins Market report explains and divides ... of revenue. The market in Europe is estimated to ... million by 2018, at a CAGR of 6.8% from ... the European Vitamins Market report, to get an idea ... glimpse of the segmentation in the European market, and ...
(Date:7/23/2014)... European Bio fertilizers Market Report defines and segments the ... of revenue. The bio fertilizers market in Europe is ... 2012 to $4,582.2 million by 2017, at a CAGR ... the TOC of the European Bio fertilizers Market report, ... , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , The bio fertilizers ...
(Date:7/23/2014)... Bethesda, MD (July 23, 2014) Statins, a class ... reduce a patient,s risk of developing Barrett,s esophagus, according ... , the official journal of the American ... risk reduction with statin use. , "Patients who received ... of having Barrett,s esophagus compared to non-users," said study ...
(Date:7/23/2014)... According to a new market research report of "Semiconductor ... SOC IP), Design Architecture (Hard IP, Soft IP), Processor ... Forecast & Analysis to 2013 - 2020", the semiconductor ... CAGR of 12.6% from 2014 to 2020 and reach ... market data tables with 60 figures spread through 337 ...
(Date:7/23/2014)... new study in East Asian women has identified three ... cancer. The research, led by Vanderbilt University investigators, was ... , While breast cancer is one of the most ... genetic risk factors for the disease have focused on ... genetic heritage and environmental exposures between East Asian women ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2
... produced audio or video for a internet directory or their ... Jeff Fisher, the developer of CounsellingBC.com ... word can provide when selecting a therapist from one of ... It,s a new phenomenon that is bound to gain ...
... The Minnesota Chiropractic Association (MCA) recently honored twelve (12) doctors for ... Madden,s in Brainerd, recognized those among them who have consistently supported ... health. Those honored were:, , ... Dr. Douglas Edwards, Albert Lea, MN ...
... and Honorary Chair Kristin Davis of acclaimed show Sex ... Hospital on Thursday, May 28th 2009, 8:00pm at Capitale to ... au Vin Affair, . It,s a first for New York ... with a musical performance by the legendary Tony Bennett, gourmet ...
... Weigh in on Kidz-Med ThermofocusWESTON, Fla., May 22 ... (Pink Sheets: ASFX) is excited to see that awareness ... is increasing surrounding taking a child,s temperature with the ... daytime talk show The Doctors , renowned pediatrician ...
... (Nasdaq: CRDC ) today announced that, on ... Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) ... $10 million stockholders, equity requirement for continued listing on ... Rule 5450(b)(1)(A) (the "Minimum Equity Requirement"). As provided by ...
... goals is what leads to well-being , , FRIDAY, May 22 ... fame may sound like a sure ticket to happiness, but ... of Rochester in New York tracked 147 college graduates, evaluating ... -- one year after graduation, and then 12 months later. ...
Cached Medicine News:Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 2Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 3Health News:Celebrities to Highlight at St. Jude's Inaugural Wine and Chocolate Gala 2Health News:Awareness Increases on New Health and Safety Technology for Kids 2Health News:Awareness Increases on New Health and Safety Technology for Kids 3Health News:Cardica Receives NASDAQ Notification 2Health News:Looks, Money, Fame Don't Bring Happiness 2
... and T-CAT have been optimized to complete ... and to interact in perfect synchronization with ... necessary treatment and patient parameters are transferred ... WAVE laser systems via diskette, mini CD ...
... ALLEGRO Analyzer has been specifically ... needed to perform safe and ... correction. All components such as ... algorithms have been optimized to ...
... & Lomb's Orbscan IIz is a fully ... beyond mere topography. Unlike current topography systems ... at standard points, the Orbscan II acquires ... to meticulously map the entire corneal surface ...
... Absolute precision demands absolute ... Bausch & Lomb Zyoptix Diagnostic ... Zywave II Wavefront Aberrometer and ... System. Individually they supply critically ...
Medicine Products: